Oxford BioMedica Share Price (OXB)

0.00 0.00 (0.00%) delayed: 4:10AM GMT
Bid price 0.00 Open price 0.00
Ask price 0.00 Prev close 7.00
High price 0.00 Spread 0.00%
Low price 0.00 Volume 0

Register now for FREE live Oxford BioMedica share prices, Oxford BioMedica stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Oxford BioMedica Level 2 Data, indepth research tools and investor commentary for Oxford BioMedica (OXB) and other London Stock Exchange equities.

Oxford BioMedica Share Price Chart

Advanced Charts >>

Register now for FREE Oxford BioMedica share price charts

Oxford BioMedica Share Price Information

Name Oxford BioMedica Epic OXB
Sector Pharmaceuticals & Biotechnology ISIN GB0006648157
Activites Oxford BioMedica plc is a biopharmaceutical company developing innovative gene-based medicines and therapeutic vaccines that aim to improve the lives of patients with high unmet medical needs. The Company's technology platform includes a highly efficient LentiVector gene delivery system, which has specific advantages for targeting diseases of the central nervous system and the eye; and a unique tumour antigen (5T4), which is an ideal target for anti-cancer therapy. Through in-house and collaborative research, Oxford BioMedica has a broad pipeline with current partners and licensees including Sanofi, Pfizer, Novartis, GlaxoSmithKline, MolMed, Sigma-Aldrich, Biogen Idec, Emergent BioSolutions, ImaginAb and Immune Design Corp. Index n/a

Oxford BioMedica Key Numbers

Latest Share Price (p) 0.00 Net Gearing (%) -10.14
Market Capitalisation (£m) 173.64 Gross Gearing (%) 31.85
Shares in issue (m) 2,568.59 Debt Ratio 6.25
P/E Ratio -15.72 Debt-to-Equity Ratio 0.14
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.47
Dividend Yield (%) 0.00 Price to book value 7.54
Dividend cover (x) 0.00 ROCE (%) -43.94
Earning per share (p) -0.43 EPS Growth (%) 45.57
52 week high / low 13.25 / 5.45 DPS Growth (%) n/a

Oxford BioMedica Director Deals

Dec.Date Type Director Pos No. of Shares
01/07/2015 BUY Martin Diggle NED 284,439
30/06/2015 BUY Martin Diggle NED 775,000
19/06/2015 BUY Martin Diggle NED 225,000
17/06/2015 BUY Andrew Heath NED 100,000
16/06/2015 BUY Tim Watts FD 116,931

More Oxford BioMedica Director Deals >>

Oxford BioMedica Company News

09:37 02/02/2016

Total Voting Rights

/* */ RNS Number : 7723N Oxford Biomedica PLC 02 February 2016               Oxford BioMedica Total Voting Rights     Oxford, UK - 2 February 2016: Oxford BioMedica plc ("Oxford BioMedica"...

07:44 29/01/2016

OXB initiates Second CART Programme for Novartis

Oxford BioMedica has initiated work on a second Chimeric Antigen Receptor T cell (CART) programme for an undisclosed indication. Under an agreement signed with Novartis in October 2014, Oxford BioMedica will undertake process development and manufacturing for the lentiviral vector associated...

07:04 29/01/2016

FLASH: OXB initiates Second CART Programme for Novartis

Story provided by StockMarketWire.com

More Oxford BioMedica Company News >>

Register now for FREE Oxford BioMedica company news

Oxford BioMedica Share Price Discussions

1 months ago

CANCER drug co. Oxford Biomedica charts (OXB)

OK so you thought the title of the other thread was out of date BUT unfortunately there is no way to edit thread titles. So here is a new title This one has got the charts at the top again & has a link to the old one....

more than 1 year ago


Very strong rumours of a further predator around. CAT,WYEYH,JOHNSON&JOHNSON,MERCK to name a few.............could be an exciting week ...!

more than 1 year ago


Very strong rumours of a further predator.........CAT,JOHNSON&JOHNSON,WYETH,MERCK to name a few. Could be an interesting week..!

Register now for FREE Oxford BioMedica share price discussions